We have experience in synthesis of biologically active substances and nanoparticles (IOC, University of Helsinki, Farmak); in the development of stimuli-responsive nanocarriers (University of Helsinki, ICTP); in quantum-chemical modelling of the active compounds and nanoparticles (IOC, UIT); in comprehensive biological testing, studies of pharmacokinetics and toxicity profiles (INPA, UFL); in scaling up and validation of proposed technologies (Farmak).
Groups
IPCB [former ICTP]
